Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
Clinical trial NCT03835533 · COMPLETED
Trial details
- NCT number
- NCT03835533
- Sponsor
- Parker Institute for Cancer Immunotherapy
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-21
- Primary completion
- 2022-10-03
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.